Related Areas

Attorneys

Chapman’s depth of health care lending experience encompasses the middle and large-cap markets

Chapman represents financial institutions in financing health care transactions from a variety of roles, including as lender’s counsel and regulatory counsel.

Although many of our clients operate in the middle market, our lending experience encompasses large-cap transactions as well. We frequently handle senior, mezzanine, second lien, silent second lien, unitranche, secured, unsecured, and first out/last out facility financings, the proceeds of which are used to finance a broad spectrum of mergers, acquisitions, and asset purchases in the health care sector, in addition to providing financing for working capital, capital expenditures, and other needs. The integrated nature of our practice helps us to provide guidance and advice on a range of health care acquisition lending concerns—from False Claims Act allegations to Health Insurance Portability and Accountability Act (HIPAA) deficiencies in acquisition targets, to company-specific compliance plan weaknesses.

Chapman’s lending team routinely counsels clients on single and multi-bank credit facilities, loan syndications, asset-based financings, and cross-border secured transactions involving multi-currency availability, letters of credit, and acceptance financing and competitive bid facilities. Our team also advises on and documents transactions involving cash flow lending for health care institutions and service providers, device manufacturers and suppliers, pharmaceutical service providers and manufacturers, health care IT providers and manufacturers, laboratory services, and other industry segments.

Acquisition Finance

Chapman has extensive experience helping lenders structure innovative solutions to finance acquisitions by both private equity firms and strategic purchasers in the continually evolving health care sector.

Chapman attorneys have been involved in deals with private equity sponsors across a wide range of health care specialties, from some of the largest diversified funds in the market to niche funds and family offices.

As health care has become one of the most regulated industries, our team has grown to address the unique yet complex acquisition and regulatory issues our clients face in the sector.

Representative Transactions